Inventor
FLORES CHRISTOPHER M
US17 patents
⚠️ This page may combine multiple inventors who share the name “FLORES CHRISTOPHER M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
11 patentsUS8697683B2Apr 15, 2014
Azetidinyl diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV2 citations72
US7705042B2Apr 27, 2010
Class of arylamide compounds useful as inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV3 citations60
US7575882B2Aug 18, 2009
Compositions and methods for identifying modulators of TRPV2
JANSSEN PHARMACEUTICA NV4 citations59
US7375203B2May 20, 2008
Canine cold- and menthol-sensitive receptor 1
JANSSEN PHARMACEUTICA NV2 citations58
US9096521B2Aug 4, 2015
Cold menthol receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations51
US7897358B2Mar 1, 2011
Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9434711B2Sep 6, 2016
Sulfonamides as TRPM8 modulators
JANSSEN PHARMACEUTICA NV0 citations49
US9090639B2Jul 28, 2015
Cold menthol receptor-1 antagonists
JANSSEN PHARMACEUTICA NV0 citations49
US8987247B2Mar 24, 2015
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
JANSSEN PHARMACEUTICA NV0 citations46
US8729064B2May 20, 2014
Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV0 citations44
US9375430B2Jun 28, 2016
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
JANSSEN PHARMACEUTICA NV0 citations36